IN8bio (INAB) Earnings Analysis
IN8bio (INAB) has no confirmed upcoming earnings date. Last quarter (2026-03-12) it missed with EPS -0.26 USD vs -0.18 USD est (-44.4%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -0.33.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does INAB next report earnings?
No confirmed upcoming earnings date is currently scheduled for INAB. This page updates as the calendar is published.
INAB earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-12 | -0.26 USD | -0.18 USD | -44.4% | Miss |
| 2025-11-06 | -0.85 USD | -1.2 USD | +29.2% | Beat |
| 2025-08-07 | -1.24 USD | -1.5 USD | +17.3% | Beat |
| 2025-03-13 | -0.04 USD | -0.07 USD | +42.9% | Beat |
Beat rate: 3/4 (75%) over reported quarters with consensus data.
INAB valuation and analyst view
| Trailing P/E | -0.33 |
|---|---|
| Trailing EPS | -4.33895 USD |
| Price / book | 0.24 |
| Dividend yield | 0.00% |
| Market cap | 0.01B |
| Analyst consensus | Buy (3 buy / 1 hold / 0 sell) |
| Avg price target | 4 USD |
Related research pages
Frequently asked questions
When is IN8bio (INAB)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for INAB. This page updates as the calendar is published.
Did INAB beat earnings last quarter?
In its 2026-03-12 report, INAB posted EPS of -0.26 USD versus a -0.18 USD estimate — a miss of 44.4%.
What is INAB's earnings track record?
Over the last 4 reported quarters with consensus data, INAB beat estimates 3 times (75%).
What is INAB's current P/E ratio and EPS?
INAB trades at a trailing P/E of -0.33 on trailing EPS of -4.338952177340154 USD.
What do analysts rate INAB?
Analyst consensus is "Buy" across 4 ratings (0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 4 USD.